These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20737641)

  • 61. On the influence of protein binding on pharmacological activity of drugs.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Apr; 99(4):2153-65. PubMed ID: 19827100
    [TBL] [Abstract][Full Text] [Related]  

  • 62. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Consideration of the linear concentration increase of the unbound drug fraction in plasma.
    Berezhkovskiy LM
    J Pharm Sci; 2009 Feb; 98(2):383-93. PubMed ID: 18704923
    [TBL] [Abstract][Full Text] [Related]  

  • 64. On the calculation of the concentration dependence of drug binding to plasma proteins with multiple binding sites of different affinities: determination of the possible variation of the unbound drug fraction and calculation of the number of binding sites of the protein.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Feb; 96(2):249-57. PubMed ID: 17051587
    [TBL] [Abstract][Full Text] [Related]  

  • 65. On the possibility of self-induction of drug protein binding.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Oct; 99(10):4400-5. PubMed ID: 20737641
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Concentration-dependent plasma protein binding: Expect the unexpected.
    Nation RL; Theuretzbacher U; Tsuji BT;
    Eur J Pharm Sci; 2018 Sep; 122():341-346. PubMed ID: 30026170
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Measurement and analysis of unbound drug concentrations.
    Wright JD; Boudinot FD; Ujhelyi MR
    Clin Pharmacokinet; 1996 Jun; 30(6):445-62. PubMed ID: 8792057
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The bioanalytical challenge of determining unbound concentration and protein binding for drugs.
    Nilsson LB
    Bioanalysis; 2013 Dec; 5(24):3033-50. PubMed ID: 24320129
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Compilation of 222 drugs' plasma protein binding data and guidance for study designs.
    Zhang F; Xue J; Shao J; Jia L
    Drug Discov Today; 2012 May; 17(9-10):475-85. PubMed ID: 22210121
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Microseparation techniques for the study of the enantioselectivity of drug-plasma protein binding.
    Escuder-Gilabert L; Martínez-Gómez MA; Villanueva-Camañas RM; Sagrado S; Medina-Hernández MJ
    Biomed Chromatogr; 2009 Mar; 23(3):225-38. PubMed ID: 19016227
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rational use of plasma protein and tissue binding data in drug design.
    Liu X; Wright M; Hop CE
    J Med Chem; 2014 Oct; 57(20):8238-48. PubMed ID: 25099658
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Drug-protein binding: a critical review of analytical tools.
    Vuignier K; Schappler J; Veuthey JL; Carrupt PA; Martel S
    Anal Bioanal Chem; 2010 Sep; 398(1):53-66. PubMed ID: 20454782
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Free drug metabolic clearance in elderly people.
    Butler JM; Begg EJ
    Clin Pharmacokinet; 2008; 47(5):297-321. PubMed ID: 18399712
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estimation of drug-protein binding parameters on assuming the validity of thermodynamic equilibrium.
    Soltés L; Mach M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 768(1):113-9. PubMed ID: 11939544
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nonlinear Protein Binding: Not What You Think.
    Deitchman AN; Singh RSP; Derendorf H
    J Pharm Sci; 2018 Jul; 107(7):1754-1760. PubMed ID: 29626534
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding.
    Hervé F; Urien S; Albengres E; Duché JC; Tillement JP
    Clin Pharmacokinet; 1994 Jan; 26(1):44-58. PubMed ID: 8137597
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Kinetic analysis of drug-protein interactions by affinity chromatography.
    Bi C; Beeram S; Li Z; Zheng X; Hage DS
    Drug Discov Today Technol; 2015 Oct; 17():16-21. PubMed ID: 26724332
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Measurement of free drug in phase I: is it useful?
    Barré J; Riant P; Tillement JP
    Fundam Clin Pharmacol; 1990; 4 Suppl 2():141s-150s. PubMed ID: 2093625
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of Changes in Free Concentrations and Drug-Protein Binding on Drug Dosing Regimens in Special Populations and Disease States.
    Celestin MN; Musteata FM
    J Pharm Sci; 2021 Oct; 110(10):3331-3344. PubMed ID: 34089711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.